Table 11.
Intake estimates of molybdenum resulting from the use of the NF as an ingredient in the intended food categories at the maximum proposed use levels and as a food supplement
| Population group | Age (years) | Total intake of Mo from the NF (Table 9) (mg per day) (a) | Highest mean Mo background intake (mg per day) (EFSA NDA Panel, 2013a) | Combined intake of Mo from NF and background diet (mg per day) | ULs (mg per day) (SCF/NDA, 2006) |
|---|---|---|---|---|---|
| Infants | < 1 | 0.009 | ND | ND | ND |
| Young children (b) | 1 to < 3 | 0.024 | 0.058 | 0.082 | 0.1 |
| Other children | 3 to < 10 | 0.057 | 0.075 | 0.13 | 0.2 |
| Adolescents | 10 to < 18 | 0.072 | 0.075 | 0.15 | 0.4 |
| Adults (c) | ≥ 18 | 0.12 | 0.16 | 0.28 | 0.6 |
Mo: molybdenum; NF: novel food; ULs: Tolerable upper intake levels; ND: not determined.
(a)
DietEx tool exposure estimate was generated on 10/6/2022. The lowest and the highest P95 observed among all EU surveys are reported in these columns (P95 based on less than 60 individuals are not considered).
(b)
Referred to as ‘toddlers’ in the EFSA food consumption comprehensive database (EFSA, 2011).
(c)
Includes elderly, very elderly, pregnant, lactating women and vegetarian.